Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latex Condom Labels Would Bear N-9, STD Warnings Under FDA Proposal

This article was originally published in The Tan Sheet

Executive Summary

Labeling for condoms that employ nonoxynol-9 should be amended to state that spermicidal lubricants may increase HIV transmission, FDA says in a proposed rule published in the Federal Register Nov. 14
Advertisement

Related Content

FDA’s Proposed Condom Label Comprehension Study Submitted To OMB
FDA’s Proposed Condom Label Comprehension Study Submitted To OMB
FDA’s Proposed Condom Label Comprehension Study Submitted To OMB
Condoms and HPV transmission
Ansell on condom labels
FDA-Proposed Label Changes For Condoms “Potentially Confusing” – C&D
Crawford Confirmation Expected To Move Issues Off The Back Burner
Nonoxynol-9 Messages Conveyed By HHS Agencies Inconsistent – GAO Report
N-9 Condom Safety GAO Evaluation Requested By Reps. Coburn, Pitts
N-9 Condom Safety GAO Evaluation Requested By Reps. Coburn, Pitts

Topics

Advertisement
UsernamePublicRestriction

Register

PS098845

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel